Placebos and principles: a trial of ondansetron.
Citron
M L
ML
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D002986:Clinical Trials as Topic / Q000592:standards*; D035061:Control Groups; D004992:Ethics, Medical; D006801:Humans; D009325:Nausea / Q000139:chemically induced / Q000517:prevention & control*; D033281:Nontherapeutic Human Experimentation; D017294:Ondansetron / Q000627:therapeutic use*; D010919:Placebos / Q000627:therapeutic use*; D035842:Research Subjects; D018570:Risk Assessment; D036302:Therapeutic Human Experimentation; D014839:Vomiting / Q000139:chemically induced / Q000517:prevention & control
D000970:Antineoplastic Agents; D010919:Placebos; D017294:Ondansetron